What does the AMH test tell me about my ovarian reserve?
The AMH test measures your ovarian reserve, indicating the quantity of eggs remaining in your ovaries, which can help assess fertility potential and guide reproductive planning.
Understanding the AMH Test and Ovarian Reserve
The Anti-Mullerian Hormone (AMH) test is a blood test that evaluates your ovarian reserve, which refers to the number of eggs remaining in your ovaries. This test is particularly useful for women who are planning for future pregnancies or undergoing fertility treatments.
How the AMH Test Works
AMH is a hormone produced by cells in the ovarian follicles. The level of AMH in your blood correlates with the number of developing follicles in your ovaries, giving an estimate of your egg count. To perform the test, a healthcare provider will draw a blood sample, which is then analyzed in a laboratory.
What the Results Mean
- High AMH Levels: May indicate a higher number of eggs and potentially a better response to fertility treatments. However, it can also be associated with conditions like polycystic ovary syndrome (PCOS).
- Low AMH Levels: Suggest a lower number of eggs, which may indicate a decreased fertility potential, especially as a woman ages.
It's important to note that while AMH levels provide valuable information about egg quantity, they do not directly predict the ability to conceive. For a comprehensive assessment of fertility, other factors and tests may need to be considered.
This information is provided by Hati Health for educational purposes and should not replace professional medical advice. Always consult with a healthcare provider about your specific medical needs and symptoms.
Book Your Anti-Mullerian Hormone (AMH) With Hati Health
Anti-Mullerian Hormone (AMH)
The Anti-Mullerian Hormone (AMH) test evaluates hormone levels in your blood to help you understand your ovarian reserve, which indicates how many eggs are left in your ovaries. This test is especially useful for women looking into fertility options, considering in vitro fertilization (IVF), or monitoring conditions such as polycystic ovary syndrome (PCOS) or early menopause.